We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » More Generic Suits Cite Brands Blocking Bioequivalency Studies
More Generic Suits Cite Brands Blocking Bioequivalency Studies
April 5, 2013
Accord Healthcare and Intas Pharmaceuticals are the latest generic drugmakers resorting to litigation to force a brand company to provide drug samples for bioequivalence testing.